| Stage | CVX | % of rev | KO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $70.1B | 100.00% | $13.4B | 100.00% | CVX ×5.24 |
| Gross profit | $33.4B | 47.75% | $8.4B | 63.15% | KO +15.4pp |
| Operating income | $17.0B | 24.32% | $4.5B | 33.37% | KO +9.1pp |
| Pre-tax income | $16.7B | 23.82% | $4.8B | 36.12% | KO +12.3pp |
| Net income | $12.2B | 17.43% | $4.1B | 30.31% | KO +12.9pp |
| Stage | CVX | KO | Gap · A − B |
|---|---|---|---|
| Revenue | $70.1B100.00% | $13.4B100.00% | CVX ×5.24 |
| Gross profit | 47.75%$33.4B | 63.15%$8.4B | KO +15.4pp |
| Operating income | 24.32%$17.0B | 33.37%$4.5B | KO +9.1pp |
| Pre-tax income | 23.82%$16.7B | 36.12%$4.8B | KO +12.3pp |
| Net income |
| 17.43%$12.2B |
| 30.31%$4.1B |
| KO +12.9pp |
No shared counterparties.